User profiles for Javier Sancho
Javier sanchoprofessor of biochemistry, universidad de zaragoza Verified email at unizar.es Cited by 7156 |
Effect of alanine versus glycine in α-helices on protein stability
THE rational design of proteins requires knowledge of the helix-forming propensities (s-values)
of the different amino acids. There is, however, considerable controversy about the …
of the different amino acids. There is, however, considerable controversy about the …
Histidine-aromatic interactions in barnase: Elevation of histidine pKa and contribution to protein stability
Aromatic side-chains are found in the vicinity of histidine residues in many proteins and
protein complexes. We have studied the interaction between a histidine residue (His18) and …
protein complexes. We have studied the interaction between a histidine residue (His18) and …
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
Parkinson’s disease (PD) is characterized by a progressive loss of dopaminergic neurons, a
process that current therapeutic approaches cannot prevent. In PD, the typical pathological …
process that current therapeutic approaches cannot prevent. In PD, the typical pathological …
[HTML][HTML] Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria
Phenylketonuria (PKU) is an inborn error of metabolism caused by mutations in phenylalanine
hydroxylase (PAH). Over 500 disease-causing mutations have been identified in humans, …
hydroxylase (PAH). Over 500 disease-causing mutations have been identified in humans, …
α-Helix stability in proteins: I. Empirical correlations concerning substitution of side-chains at the N and C-caps and the replacement of alanine by glycine or serine at …
The importance of amino acid side-chains in helix stability has been investigated by making
a series of mutations at the N-caps, C-caps and internal positions of the solvent-exposed …
a series of mutations at the N-caps, C-caps and internal positions of the solvent-exposed …
Circular dichroism studies of barnase and its mutants: characterization of the contribution of aromatic side chains
MATERIALS AND METHODS Materials. Urea (ultrapure enzyme grade) was obtained from
Bethesda Research Laboratories,(Bethesda, MD). SP-Trisacryl was from IBF (Villeneuve-La-…
Bethesda Research Laboratories,(Bethesda, MD). SP-Trisacryl was from IBF (Villeneuve-La-…
Miglustat (NB-DNJ) works as a chaperone for mutated acid β-glucosidase in cells transfected with several Gaucher disease mutations
…, JC Rodríguez-Rey, P Giraldo, J Sancho… - Blood Cells, Molecules …, 2005 - Elsevier
Gaucher disease (GD) is a disorder of glycosphinglipid metabolism caused by deficiency of
lysosomal acid β-glucosidase (GC), resulting in progressive deposition of glucosylceramide …
lysosomal acid β-glucosidase (GC), resulting in progressive deposition of glucosylceramide …
[HTML][HTML] The active site of pepsin is formed in the intermediate conformation dominant at mildly acidic pH
Pepsin is an aspartic protease that acts in food digestion in the mammal stomach. An optimal
pH of around 2 allows pepsin to operate in its natural acidic environment, while at neutral …
pH of around 2 allows pepsin to operate in its natural acidic environment, while at neutral …
[HTML][HTML] ProtSA: a web application for calculating sequence specific protein solvent accessibilities in the unfolded ensemble
Background The stability of proteins is governed by the heat capacity, enthalpy and entropy
changes of folding, which are strongly correlated to the change in solvent accessible surface …
changes of folding, which are strongly correlated to the change in solvent accessible surface …
[HTML][HTML] High-throughput screening methodology to identify alpha-synuclein aggregation inhibitors
An increasing number of neurodegenerative diseases are being found to be associated with
the abnormal accumulation of aggregated proteins in the brain. In Parkinson’s disease, this …
the abnormal accumulation of aggregated proteins in the brain. In Parkinson’s disease, this …